SWOG clinical trial number
CTSU/NRG-BR004

A Randomized, Double-Blind, Phase III Trial of Paclitaxel/ Trastuzumab/ Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer

Open
Abbreviated Title
A Randomized, Double-Blind, Phase III Trial of Paclitaxel/ Trastuzumab/ Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
Status Notes
Activated by NRG: 3/12/19.
Activated by SWOG: 3/15/19.
Activated
03/15/2019
Participants
ALL NATIONAL CLINICAL TRIALS NETWORK MEMBERS

Eligibility Criteria Expand/Collapse

Please see the protocol on the CTSU website (http://www.ctsu.org/) for eligibility criteria.